The 3rd AGB Golden Top Forum, centered on genome-wide selection technologies, convened in Quanzhou, Fujian Province, in March 2025. Li Zhi, Chairman of LASO Biotech, underscored the critical role of breeding technology and the strategic importance of gene chip technology.

(left) Li Zhi (Chairman of LASO Biotech), (Fourth From the Left)

Liu Chaojun (President of LASO Biotech), and (Second from the Left) Su Guosheng (Professor)  

Li Zhi (Chairman of LASO Biotech)

After six years of sustained R&D and over 200 million yuan in social capital investment, LASO Biotech has commercialized its proprietary, cost-effective genetic testing and molecular breeding solutions. Our company has collaborated with multiple institutions to develop a series of adaptable porcine breeding microarray, now deployed across diverse industrial applications.

LASO Biotech aims to increase breeding selection intensity tenfold within three years and a hundredfold within five years, while slashing 80% of breeding cycle time, promoting efficient industrial development.